13F-HR filed by BAUPOST GROUP LLC/MA
BAUPOST GROUP LLC/MA filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-13, with 32 holding rows worth $11,047,254,000.
- Accession
- 0001567619-19-016587
- Filer
- CIK 1061768
- Filed
- 2019-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 32 entries on the cover page, a total value of $11,047,254,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $11,047,254,000 with VALUE read as thousands by filing date, 13F file number 028-07120. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LIBERTY GLOBAL PLC | G5480U120 | SHS CL C | 41,937,674 | $1,112,606,000 | thousands by filing date | |
| VIASAT INC | 92552V100 | COM | 13,732,068 | $1,109,826,000 | thousands by filing date | |
| FOX CORP CL A COM | 35137L105 | Stock | 27,322,720 | $1,001,104,000 | thousands by filing date | |
| EBAY INC. COM | 278642103 | Stock | 24,146,000 | $953,767,000 | thousands by filing date | |
| CHENIERE ENERGY INC COM NEW | 16411R208 | Stock | 10,674,135 | $730,645,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 3,679,549 | $616,067,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 13,000,000 | $589,550,000 | thousands by filing date | |
| QORVO INC COM | 74736K101 | Stock | 8,681,181 | $578,253,000 | thousands by filing date | |
| PG&E CORP COM | 69331C108 | Stock | 24,500,000 | $561,540,000 | thousands by filing date | |
| CBS CORP NEW | 124857202 | CL B | 10,000,000 | $499,000,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 2,595,011 | $348,744,000 | thousands by filing date | |
| SYNCHRONYFINL | 87165B103 | STOK | 9,260,557 | $321,064,000 | thousands by filing date | |
| TESLA INC | 88160RAD3 | NOTE 2.375% 3/1 | 300,000,000 | $295,542,000 | thousands by filing date | principal |
| COLONY CAPITAL INC | 19626G108 | CL A COM | 49,687,370 | $248,437,000 | thousands by filing date | |
| UNIVAR INC | 91336L107 | COMMON STOCK | 9,500,000 | $209,380,000 | thousands by filing date | |
| FOX CORP | 35137L204 | CL B COM | 5,680,307 | $207,502,000 | thousands by filing date | |
| LIBERTY GLOBAL PLC | G5480U104 | SHS CL A | 7,440,705 | $200,825,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 2,214,192 | $188,782,000 | thousands by filing date | |
| TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS | 874060205 | ADR | 9,438,003 | $167,053,000 | thousands by filing date | |
| ANTERO RESOURCES CORP COM | 03674X106 | Stock | 28,587,791 | $158,090,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 9,309,168 | $152,019,000 | thousands by filing date | |
| NEXSTAR MEDIA GROUP INC COMMON STOCK | 65336K103 | Stock | 1,397,755 | $141,173,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 7,000,000 | $140,770,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 24,471,453 | $118,442,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 8,844,239 | $109,372,000 | thousands by filing date | |
| XPO INC COM | 983793100 | Stock | 1,500,000 | $86,715,000 | thousands by filing date | |
| VERITIV CORP | 923454102 | COM | 3,564,439 | $69,221,000 | thousands by filing date | |
| TRILOGY METALS INC | 89621C105 | COMMON STOCK | 13,641,368 | $39,766,000 | thousands by filing date | |
| SINCLAIR BROADCAST GROUP INC | 829226109 | CL A | 549,423 | $29,466,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,267,171 | $27,254,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA | 88339KAA0 | NOTE 3.250%11/0 | 30,000,000 | $25,725,000 | thousands by filing date | principal |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 2,394,498 | $9,554,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-016587 | this filing | 2019-08-13 | acceptance time not in the bulk data set |